J-REGISTER: real-world study of Japanese patients with <i>EGFR</i> mutation-positive NSCLC treated with first-line afatinib

Authors

Institutions

Publication Details

Journal
Future Oncology
Published
2025-06-07
DOI
https://doi.org/10.1080/14796694.2025.2514423
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

J-REGISTER: real-world study of Japanese patients with EGFR mutation-positive NSCLC treated with first-line afatinib

Takashi Kijima, Teppei Yamaguchi, H. Daga, H. Tanaka et al.
2 links
Future Oncology
Lung Cancer Treatments and Mutations
article

J-REGISTER: real-world study of Japanese patients with EGFR mutation-positive NSCLC treated with first-line afatinib

Takashi Kijima, Teppei Yamaguchi, H. Daga, H. Tanaka, Masaya Mizushima
article en

Abstract

No abstract available for this paper.
Future OncologyVol. 21(16)
Hirosaki University (JP), Osaka City General Hospital (JP), Boehringer Ingelheim (Japan) (JP), Aichi Cancer Center (JP), Boehringer Ingelheim (Philippines) (PH), Hyogo University (JP)
Boehringer Ingelheim
Zero hunger
Openalex Percentile: Top 78%
Lung Cancer Treatments and Mutations
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.